BNT324/DB-1311 Receives Quick Monitor Designation From FDA for mCRPCQuick monitor designation has been granted by the FDA to the antibody-drug conjugate (ADC) BNT324/DB-1311...
The market simply turned extra aggressive with the entry of St. Joseph’s Well being: Does Central New York have sufficient most cancers sufferers?
By...
Share on PinterestRecurrent glioblastoma, essentially the most aggressive type of mind tumor, has no efficient remedy.A brand new type of CAR T remedy,...
New research on potential advantages of double mastectomy for breast most cancersABC Information’ medical correspondent Dr. Darien Sutton breaks down the most recent...
